Retatrutide · 10 mg
$43.00
VALTHERA / A NEW STANDARD OF INQUIRY
FORGED
BEYOND LIMITS.
Where timeless resolve meets the frontier of biotechnology. A new visual language for research, precision, and discovery.
FORTITUDO / FIDES / SCIENTIASCROLL TO EXPLORE ↓
✧ PRECISION IN EVERY DETAIL✧ RESEARCH-LED THINKING✧ BUILT FOR WHAT'S NEXT
01 / THE VALTHERA PHILOSOPHY
A legacy of strength.
A future of science.
Inspired by the courage of those who ascend despite adversity. Designed with the clarity, discipline, and restraint of tomorrow's laboratory.
Browse research compound listings and explore estimated totals in the demonstration cart. Prices are proposed and do not represent an offer to sell.RESEARCH CATALOG · CONCEPT RESEARCH CATALOG · CONCEPT RESEARCH CATALOG · CONCEPT RESEARCH CATALOG · CONCEPT RESEARCH CATALOG · CONCEPT RESEARCH CATALOG · CONCEPT RESEARCH CATALOG · CONCEPT RESEARCH CATALOG · CONCEPT RESEARCH CATALOG · CONCEPT RESEARCH CATALOG · CONCEPT RESEARCH CATALOG · CONCEPT RESEARCH CATALOG · CONCEPT RESEARCH CATALOG · CONCEPT n">
Retatrutide · 20 mg
$67.50
Retatrutide · 30 mg
$89.91
GHK-Cu · 50 mg
$27.00
BPC-157 · 10 mg
$37.80
TB-500 · 5 mg
$43.00
KLOW · 80 mg
$60.00
Tesamorelin · 10 mg
$60.00
MOTS-c · 10 mg
$40.00
Ipamorelin · 10 mg
$40.00
NAD+ · 500 mg
$50.00
SS-31 · Size to confirm
$50.00
Glutathione · 1500 mg
$60.00
COMPOUND PROFILE / VL-001
Retatrutide
30 MG · LABEL CONCEPTAn investigational triple receptor agonist being studied for its activity at the GLP-1, GIP, and glucagon receptors.
Research classificationTriple receptor agonist
Receptor activityGLP-1 / GIP / Glucagon
Visual label30 mg · concept only
Regulatory statusInvestigational / not FDA-approved
RESEARCH INFORMATION ONLY. This is a design mockup, not a verified physical product or an offer to sell. No human or veterinary use, dosing, efficacy, or quality assurance is implied.
READ RESEARCH FAQ ↗03 / RESEARCH CATALOG
Precision in every detail.
Reference comparison and proposed VALTHERA catalog figures. Competitor prices are unverified; added item prices are user-provided targets.
| Research compound / size | Reference price | VALTHERA target |
|---|---|---|
| Retatrutide · 10 mg | $47.77 | $43.00 |
| Retatrutide · 20 mg | $75.00 | $67.50 |
| Retatrutide · 30 mg | $99.90 | $89.91 |
| GHK-Cu · 50 mg | $30.00 | $27.00 |
| BPC-157 · 10 mg | $42.00 | $37.80 |
| TB-500 · 5 mg | $47.77 | $43.00 |
| KLOW · 80 mg | — | $60.00 |
| Tesamorelin · 10 mg | — | $60.00 |
| MOTS-c · 10 mg | — | $40.00 |
| Ipamorelin · 10 mg | — | $40.00 |
| NAD+ · 500 mg | — | $50.00 |
| SS-31 · Size to confirm | — | $50.00 |
| Glutathione · 1500 mg | — | $60.00 |
04 / THE STANDARD
Designed with intent.
The principles guiding how research information should be presented: clarity, accuracy, and transparency.
01 /
Clarity first.
Readable compound identity and investigational status, without vague promises or inflated claims.
02 /
Evidence matters.
Space for source-backed scientific context and batch-specific documentation if independently verified in the future.
03 /
Precision in design.
Clean hierarchy, refined contrast, and a monochrome identity crafted to feel confident without excess.
VALTHERA / THE ASCENT CONTINUES
THE SUMMIT IS NOT THE END.
IT IS THE BEGINNING.
Every discovery begins with the willingness to climb beyond what is known.
05 / INFORMATION
Research notes.
What is retatrutide?
Retatrutide is an investigational molecule designed to activate GLP-1, GIP, and glucagon receptors. This page is an educational compound overview.
Is retatrutide FDA-approved?
No. Retatrutide is investigational and is not FDA-approved. This site does not provide medical advice or instructions for use.
Can I purchase compounds from this website?
No. VALTHERA LABS is presented here as a design and educational website concept. There is no cart, checkout, ordering, or payment processing.
Are the product images proof of laboratory testing?
No. The imagery is conceptual. No claim of batch testing, purity, sterility, or inventory verification is made.